Clinical Trials Directory

Trials / Unknown

UnknownNCT05421845

Prevention of Gestational Diabetes Mellitus With Lifestyle Intervention Among Women of Advanced Maternal Age.

Prevention of Gestational Diabetes Mellitus With Mobile- and Hospital-based Lifestyle Intervention Among Women of Advanced Maternal Age: a Randomized Controlled Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
346 (estimated)
Sponsor
Peking University · Academic / Other
Sex
Female
Age
35 Years
Healthy volunteers
Accepted

Summary

This is a single-blind randomized controlled trial, aiming to evaluate the preventive effects of mobile-based combining with hospital-based lifestyle interventions on GDM among women with advanced maternal age. It will be conducted in Beijing, with a sample size of 346. All eligible pregnant women will be randomly assigned to either the intervention or control group, and followed up to delivery.

Detailed description

After the adjustment of fertility policy in China, the prevalence of advanced maternal age (AMA) has become a crucial issue in maternal health care. AMA can greatly increase the risk of gestational diabetes mellitus (GDM) during pregnancy. However, there is still a lack of high-quality evidence on GDM preventive interventions for AMA pregnancy in China. In this randomized study, the investigators aim to examine whether mobile-based combining with hospital-based lifestyle interventions have preventive effects on GDM in AMA pregnancies. The investigators will enroll a total of 346 singleton pregnant women in Peking University First Hospital and randomly assign them to either the intervention or control group. Information of maternal characteristics will be obtained at recruitment. At each prenatal visit, weight and blood pressure of all participants will be measured. For each participant, fasting venous blood samples will be collected at \<14 weeks of gestation, 24-28 weeks of gestation and pre-labor, and respectively assayed for fasting plasma glucose, glycated hemoglobin. The primary outcome is the incidence of GDM. The secondary outcomes include maternal glycated hemoglobin level, maternal fasting plasma glucose level, maternal complications, pregnancy outcomes, etc.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmobile-based combining with hospital-based lifestyle interventionsThe same as that stated in arm descriptions.

Timeline

Start date
2022-07-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2022-06-16
Last updated
2022-06-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05421845. Inclusion in this directory is not an endorsement.